-
Development and validation of an individualized and weighted Myeloma Prognostic Score System (MPSS) in patients with newly diagnosed multiple myeloma
In January 2024, a study led by Professor Gang An from Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College was published in the international academic journal ——American Journal of Hematology(IF=12.8). The title of the study is “Development and validation of an individualized and weighted Myeloma Prognostic…
-
MAF translocation remains a strong prognostic factor despite concurrent chromosomal abnormalities
In January 2024, a groundbreaking study spearheaded by Professor Gang An from Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, made its debut in the esteemed journal Haematologica (IF=11.047). The research, titled “MAF translocation remains a strong prognostic factor despite concurrent chromosomal abnormalities” marks a significant…
-
Highlights of the Annual Conference | Dr. Jie Li: Comorbidity and Management of Diabetes and Non-Alcoholic Fatty Liver Disease (NAFLD) in the New Era
The 21st National Conference on Viral Hepatitis and Hepatology, and the Annual Meetings of the Chinese Society of Hepatology and the Chinese Society of Infectious Diseases, took place from December 22nd to 24th, 2023, in Chengdu, Sichuan Province. This conference, co-hosted by the Chinese Medical Association, the Chinese Society of Hepatology, and the Chinese Society…
-
Expert Insight | Dr. XiaoheXiao: Precision Medication – Making Traditional Chinese Medicine the Guardian of the Body’s “Chemical Factory”
The liver, as the “chemical factory” of the human body, is responsible for the synthesis and metabolism of various crucial substances, while also serving as the “detoxification center” for harmful waste and toxins. However, the liver faces numerous challenges, including external factors such as viruses, bacteria, alcohol, drugs, and internal factors like self-consumption, immune imbalance,…
-
Expert’s Insight | Dr. Chenghai Liu: ” Dual Antagonism” Strategy Assists in the Full Course Management of Chronic Liver Disease
Improving the prognosis of chronic viral hepatitis is a crucial goal in clinical treatment. Chronic hepatitis B (CHB) has a wide incidence, and its severe harm mainly stems from the progression from liver fibrosis to cirrhosis, leading to decompensated cirrhosis and liver cancer, seriously threatening the patient’s life and health. Therefore, reversing early cirrhosis is…
-
Annual Meeting Exclusive Interview | Dr. Xiong Ma: Comparing International and Chinese Guidelines for Autoimmune Hepatitis Treatment
Autoimmune Hepatitis (AIH) is an acute or chronic liver inflammatory disease caused by unknown immune abnormalities. Without timely treatment, it can progress to liver cirrhosis, liver failure, and even lead to death. The diagnostic scoring systems and criteria proposed in current domestic and international guidelines have significantly advanced the diagnosis and treatment of AIH. Moreover,…
-
“Year-EndAnnual Review | Professor Jia JidongDr. Jidong Jia: Latest Developments in the Clinical Diagnosis and Treatment of Primary Biliary Cholangitis”
Primary Biliary Cholangitis (PBC) is an autoimmune liver disease that predominantly affects middle-aged women. The exact cause and mechanism of its onset are not yet fully understood. It is thought to be related to genetic factors and their interaction with environmental factors leading to immune dysregulation. Currently, there are few effective medications available for clinical…
-
“Annual Review | Professor Yang MingDr. Ming Yang: Latest Developments in Systemic Treatment of Biliary Tract Cancer”
In the field of biliary tract cancer (BTC) treatment, significant advancements have been made recently. BTC is a highly heterogeneous group of malignancies originating from the epithelium of the bile ducts, presenting challenges in treatment and typically leading to short survival periods for patients. Traditionally, the primary treatment for advanced BTC has been chemotherapy. However,…
Connecting Medical Expertise through Media